Benzinga - Thu, 04 Mar 2021 09:11:14 -0400
Benzinga - Thu, 04 Mar 2021 08:01:05 -0400
Benzinga - Tue, 23 Feb 2021 05:09:45 -0400
Benzinga - Fri, 12 Feb 2021 17:58:09 -0400
Benzinga - Mon, 08 Feb 2021 11:34:01 -0400
Benzinga - Fri, 29 Jan 2021 05:47:01 -0400
Benzinga - Thu, 28 Jan 2021 13:35:16 -0400
Benzinga - Thu, 21 Jan 2021 06:03:57 -0400
load more
Sector: Health Care.Industry: Biotechnology
BioLine Rx Ltd is a clinical-stage biopharmaceutical development company with a strategic focus on oncology. Its development and commercialization pipeline consists of two clinical-stage therapeutic candidates - Motixafortide, a novel peptide for the treatment of solid tumors, hematological malignancies and stem cell mobilization, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, it has an off- strategy, a legacy therapeutic product called BL-5010 for the treatment of skin lesions.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-19
REV
Q4 2020Est.ActualSurprise
EPS-0.270-0.040 0.2300
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
BLRXBioLine Rx-2.03%123M

BioLine Rx Company Questions & Answers

Q

How do I buy BioLine Rx (BLRX) stock?

A

You can purchase shares of BioLine Rx (NASDAQ: BLRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are BioLine Rx's (BLRX) main competitors?

Q

What is the target price for BioLine Rx?

A

The latest price target for BioLine Rx (NASDAQ: BLRX) was reported by HC Wainwright & Co. on 2021-02-23. The analyst firm set a price target for 19.00 expecting BLRX to rise to within 12 months (a possible 557.44% upside). 2 analyst firms have reported ratings in the last year.

Q

How much is BioLine Rx (BLRX) stock ?

A

The stock price for BioLine Rx (NASDAQ: BLRX) is $2.89 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next BioLine Rx (BLRX) dividend?

A

There are no upcoming dividends for BioLine Rx.

Q

When is BioLine Rx (NASDAQ:BLRX) reporting earnings?

A
BioLine Rx’s Q1 earnings are confirmed after-market from now on May 19, 2021.
Q

When is the upcoming split for BLRX?

A

There is no upcoming split for BioLine Rx.